Results 151 to 160 of about 5,801 (166)

Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data

Journal of Clinical Medicine, 2023
Domenico Motola, Nicola Montanaro, Greta Santi Laurini   +2 more
exaly  

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study

Pathogens, 2022
Jacopo Vecchiet, Paola Borrelli, Michela Pontolillo   +2 more
exaly  

Imbalance in baseline characteristics in molnupiravir trials

BMJ, 2022
openaire   +2 more sources

Stability Indicating HPTLC Method of Molnupiravir and Comparative Study of Degradant with Marketed Molnupiravir Impurity- A

2022
Tekade, Mayur, Patil, Pallavi
openaire   +1 more source

A Short Synthesis of Molnupiravir

Synfacts, 2020
openaire   +1 more source

Flecainide/Molnupiravir

Reactions Weekly
openaire   +1 more source

Amiodarone/molnupiravir

Reactions Weekly
openaire   +1 more source

IMPROVED PROCESS FOR MOLNUPIRAVIR

2022
SRINIVAS REDDY DESI REDDY, SUBBA REDDY PEKETI, VENKATA GNANESWARA RAO GUTTIKONDA, SIVA REDDY DESI REDDY   +3 more
openaire   +1 more source

Molnupiravir/ocrelizumab

Reactions Weekly
openaire   +1 more source

Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study

Clinical Microbiology and Infection
Doron Netzer, Alon Peretz, Gil Lavie
exaly